Posted on

Kyberlife raises Pre-Series A funding round led by PE Global, angel investors

The Kyberlife management team

Kyberlife –a Singapore-based e-commerce marketplace startup for life sciences, pharmaceutical, and healthcare industries– today announced an undisclosed Pre-Series A funding round led by PE Global, the venture capital (VC) arm of PANSAR Group, and industry leaders such as James Simkins (CEO of GETZ Healthcare), Dr Michael Gorriz (Global Group Chief Information Officer of Standard Chartered Bank), and Dr Soenke Weissenborn (Group Operations Director for IDS Immunodiagnostics Systems).

Existing investors such as Rapzo Capital and Amatar Investment also participated in the funding round.

Together with a seed funding garnered in August last year, Kyberlife said that it has raised “around one million Singapore dollars.” This Pre-Series A funding round is claimed to be oversubscribed.

In an email to e27, Kyberlife stated that the fresh funds will be used to develop user traction and growth in Singapore, and for regional marketing purposes.

Kyberlife facilitates the buying and selling between principals in the life sciences, pharmaceutical, and healthcare industries with their B2B consumers of scientists/researchers, institutions, academia, businesses, laboratories and hospitals.

Also Read: Breaking the taboo: Meet the Singapore-based startups that are working to provide access to sexual healthcare

“With Kyberlife we are solving an imminent and overlooked problem within these traditional industries where consumers experience a laborious process of searching for products while principals have little control of their products on third-party platforms. It is our mission to achieve an efficient and active network for the community by being the one-stop shop for both parties to communicate and transact with each other. Consumers will experience higher transparency across products for easy sourcing while the principals will retain full control over their products,” said Kyberlife Co-Founder and CEO Ryan James Lim.

The company has secured partnerships with multinational companies such as Eppendorf, Merck, Roche and Tipbio Systems.

In a press statement, Lim said that there are many life sciences principals in Europe and the US who do not intend to enter Asia and Southeast Asia due to high set-up cost, exacerbated by COVID-19 travel-related restrictions. But with Kyberlife, they now have the option to reach out to their consumers conveniently and without any risk – to new market segments, via its open marketplace.

Kyberlife was founded and incorporated in Singapore by three founding partners: Ryan James Lim (CEO), Michael Tillmann (Chairman) and Wesley Lim (China Channel Lead).

Prior to Kyberlife, Ryan Lim and Wesley Lim started an e-commerce marketplace for B2C users in the cosmetics industry. Its technology was then absorbed into Kyberlife.

Tillmann has over 25 years of experience in senior executive and supervisory board positions for multinational companies in the pharmaceutical and
diagnostics industry. He held the position of President and CEO for Roche Diagnostics in North America and before that, in Asia Pacific and Europe.

He also founded a polymerase chain reaction (PCR) company, Vela Diagnostics where he met and formed a mentor-mentee relationship with Ryan Lim, who had worked as an intern at his company.

Ready to meet new startups to invest in? We have more than hundreds of startups ready to connect with potential investors on our platform. Create or claim your Investor profile today and turn on e27 Connect to receive requests and fundraising information from them.

Image Credit: Cheryl Faith Ho for Kyberlife

The post Kyberlife raises Pre-Series A funding round led by PE Global, angel investors appeared first on e27.